Cargando…
Is Free Testosterone Concentration a Prognostic Factor of Survival in Chronic Renal Failure (CRF)?
BACKGROUND: Lowered testosterone level in CRF patients is associated with elevated risk of death due to cardiovascular reasons, and is influenced by many factors, including acid-base balance disorders. Aims: evaluation of testosterone concentration (TT) and free testosterone concentration (fT) in pr...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642367/ https://www.ncbi.nlm.nih.gov/pubmed/26546587 http://dx.doi.org/10.12659/MSM.894146 |
_version_ | 1782400351895289856 |
---|---|
author | Niemczyk, Stanisław Niemczyk, Longin Szamotulska, Katarzyna Bartoszewicz, Zbigniew Romejko-Ciepielewska, Katarzyna Gomółka, Małgorzata Saracyn, Marek Matuszkiewicz-Rowińska, Joanna |
author_facet | Niemczyk, Stanisław Niemczyk, Longin Szamotulska, Katarzyna Bartoszewicz, Zbigniew Romejko-Ciepielewska, Katarzyna Gomółka, Małgorzata Saracyn, Marek Matuszkiewicz-Rowińska, Joanna |
author_sort | Niemczyk, Stanisław |
collection | PubMed |
description | BACKGROUND: Lowered testosterone level in CRF patients is associated with elevated risk of death due to cardiovascular reasons, and is influenced by many factors, including acid-base balance disorders. Aims: evaluation of testosterone concentration (TT) and free testosterone concentration (fT) in pre-dialysis and dialysis patients; assessment of TT and fT relationships with biochemical parameters; evaluation of prognostic importance of TT and fT in predicting patient survival. MATERIAL/METHODS: 4 groups of men: 14 – on hemodialysis (HD), 13 – on peritoneal dialysis (PD), 9 – with chronic renal failure (CRF) and 8 – healthy (CG), aged 56±17, 53±15, 68±12, 43±10 years, respectively. TT and biochemical parameters were measured; fT was calculated. RESULTS: The lowest TT and fT were observed in HD and CRF, the highest – in CG (p=0.035 for TT; p=0.007 for fT). fT in CRF and CG were different (p=0.031). TT and age was associated in HD (p=0.026). Age and fT was strongly associated in PD (p<0.001). After adjustment for age, TT was negatively associated with BMI (p=0.013) and fT was positively associated with HCO3 level (p=0.007). fT was lower in those who died during 5 years of observation than in survivors (p=0.009). We have found that, opposite to TT, fT appeared to be a better predictor of 5-year survival than age. After combining pH and HCO3 levels into a single variable – no acidosis, acidosis with HCO3 normal serum level, acidosis with low concentrations of HCO3 and adjustment for age and the study group – a trend toward the lowest values of free testosterone in decompensated acidosis was observed (p(trend)=0.027). Such a trend was not seen for testosterone concentrations (p(trend)=0.107). CONCLUSIONS: Total and free testosterone levels were lower in HD and pre-dialysis than in healthy patients. Free testosterone level may predict long-term survival better than age. Total and free testosterone levels are lower in metabolic acidosis and total and free testosterone levels were positively associated with HCO3 level. |
format | Online Article Text |
id | pubmed-4642367 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | International Scientific Literature, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-46423672015-11-23 Is Free Testosterone Concentration a Prognostic Factor of Survival in Chronic Renal Failure (CRF)? Niemczyk, Stanisław Niemczyk, Longin Szamotulska, Katarzyna Bartoszewicz, Zbigniew Romejko-Ciepielewska, Katarzyna Gomółka, Małgorzata Saracyn, Marek Matuszkiewicz-Rowińska, Joanna Med Sci Monit Clinical Research BACKGROUND: Lowered testosterone level in CRF patients is associated with elevated risk of death due to cardiovascular reasons, and is influenced by many factors, including acid-base balance disorders. Aims: evaluation of testosterone concentration (TT) and free testosterone concentration (fT) in pre-dialysis and dialysis patients; assessment of TT and fT relationships with biochemical parameters; evaluation of prognostic importance of TT and fT in predicting patient survival. MATERIAL/METHODS: 4 groups of men: 14 – on hemodialysis (HD), 13 – on peritoneal dialysis (PD), 9 – with chronic renal failure (CRF) and 8 – healthy (CG), aged 56±17, 53±15, 68±12, 43±10 years, respectively. TT and biochemical parameters were measured; fT was calculated. RESULTS: The lowest TT and fT were observed in HD and CRF, the highest – in CG (p=0.035 for TT; p=0.007 for fT). fT in CRF and CG were different (p=0.031). TT and age was associated in HD (p=0.026). Age and fT was strongly associated in PD (p<0.001). After adjustment for age, TT was negatively associated with BMI (p=0.013) and fT was positively associated with HCO3 level (p=0.007). fT was lower in those who died during 5 years of observation than in survivors (p=0.009). We have found that, opposite to TT, fT appeared to be a better predictor of 5-year survival than age. After combining pH and HCO3 levels into a single variable – no acidosis, acidosis with HCO3 normal serum level, acidosis with low concentrations of HCO3 and adjustment for age and the study group – a trend toward the lowest values of free testosterone in decompensated acidosis was observed (p(trend)=0.027). Such a trend was not seen for testosterone concentrations (p(trend)=0.107). CONCLUSIONS: Total and free testosterone levels were lower in HD and pre-dialysis than in healthy patients. Free testosterone level may predict long-term survival better than age. Total and free testosterone levels are lower in metabolic acidosis and total and free testosterone levels were positively associated with HCO3 level. International Scientific Literature, Inc. 2015-11-07 /pmc/articles/PMC4642367/ /pubmed/26546587 http://dx.doi.org/10.12659/MSM.894146 Text en © Med Sci Monit, 2015 This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License |
spellingShingle | Clinical Research Niemczyk, Stanisław Niemczyk, Longin Szamotulska, Katarzyna Bartoszewicz, Zbigniew Romejko-Ciepielewska, Katarzyna Gomółka, Małgorzata Saracyn, Marek Matuszkiewicz-Rowińska, Joanna Is Free Testosterone Concentration a Prognostic Factor of Survival in Chronic Renal Failure (CRF)? |
title | Is Free Testosterone Concentration a Prognostic Factor of Survival in Chronic Renal Failure (CRF)? |
title_full | Is Free Testosterone Concentration a Prognostic Factor of Survival in Chronic Renal Failure (CRF)? |
title_fullStr | Is Free Testosterone Concentration a Prognostic Factor of Survival in Chronic Renal Failure (CRF)? |
title_full_unstemmed | Is Free Testosterone Concentration a Prognostic Factor of Survival in Chronic Renal Failure (CRF)? |
title_short | Is Free Testosterone Concentration a Prognostic Factor of Survival in Chronic Renal Failure (CRF)? |
title_sort | is free testosterone concentration a prognostic factor of survival in chronic renal failure (crf)? |
topic | Clinical Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642367/ https://www.ncbi.nlm.nih.gov/pubmed/26546587 http://dx.doi.org/10.12659/MSM.894146 |
work_keys_str_mv | AT niemczykstanisław isfreetestosteroneconcentrationaprognosticfactorofsurvivalinchronicrenalfailurecrf AT niemczyklongin isfreetestosteroneconcentrationaprognosticfactorofsurvivalinchronicrenalfailurecrf AT szamotulskakatarzyna isfreetestosteroneconcentrationaprognosticfactorofsurvivalinchronicrenalfailurecrf AT bartoszewiczzbigniew isfreetestosteroneconcentrationaprognosticfactorofsurvivalinchronicrenalfailurecrf AT romejkociepielewskakatarzyna isfreetestosteroneconcentrationaprognosticfactorofsurvivalinchronicrenalfailurecrf AT gomołkamałgorzata isfreetestosteroneconcentrationaprognosticfactorofsurvivalinchronicrenalfailurecrf AT saracynmarek isfreetestosteroneconcentrationaprognosticfactorofsurvivalinchronicrenalfailurecrf AT matuszkiewiczrowinskajoanna isfreetestosteroneconcentrationaprognosticfactorofsurvivalinchronicrenalfailurecrf |